Wang Xiaolin 4
4 · Revolution Medicines, Inc. · Filed Sep 21, 2021
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
[F1][F2]2021-09-17$30.02/sh−250$7,505→ 12,195 total
Footnotes (2)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Includes 9,800 RSUs.
Signature
/s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang|2021-09-21